CSS Launches Global Provision of Radiolabelling Services

November 25, 2005

CSS Launches Global Provision of Radiolabelling Services

CSS – one of Europe’s leading providers of chemistry, analytical and manufacturing services – announced today (01 Nov 2005) the launch of Carbon-14 labelling services on 01 Dec 2005.

CSS will provide radiolabelling services for the development of compounds from drug discovery to launch of API.  This full service provision will include: synthesis of metabolites; intermediates and API.  In an unusual departure from the radiolabelling service provided by others, CSS will also offer GMP synthesis of Carbon-14 labelled API for clinical studies.

David Moody, VP Commercial Operations, comments; “This investment provides our customers with both a highly competitive stand-alone service and the opportunity to meet their most complex needs.  In this regard, early indications are that many of our customers are interested in the supply of radiolabelled peptides, chirals and cytotoxics.  This is another key step towards fulfilling our ambition of delivering diverse, differentiated and highly ‘connected’ services.”

CSS provides organic chemistry expertise, process development, manufacturing and technology transfer capabilities. It is an affiliate company of the Almac Sciences Group, which provides pharmaceutical services across drug discovery, manufacture of API, clinical trials and drug product manufacture. Its operations are based throughout the UK and USA.

Any interested companies should contact Rosaleen McGuckin at CSS on:

+44(0)28 38395830

+44(0)7803 830775

[email protected]

All Media Enquiries:

Darlene McCormick


Tel +44(0)2890 248805

Email: [email protected]


Back to news